Loading organizations...
Loading organizations...

NUE Life Health is a technology company.
NUE Life Health provides a comprehensive telehealth platform that integrates ketamine therapy with an interactive companion app and virtual aftercare. The company delivers a next-generation mental wellness solution designed to enhance brain function, performance, and overall longevity, leveraging evidence-based treatments within a structured therapeutic ecosystem. This approach aims to offer accessible and holistic support for mental well-being.
Founded in 2020 by Juan Pablo Cappello, Christina Getty, and Kazi Hassan, the company emerged from the insight that traditional mental health approaches often mask symptoms rather than address underlying causes. The founders recognized a growing need for alternative, root-cause-focused therapies, particularly in the realm of psychedelic-assisted treatments, driving them to create a technology-enabled solution that bridges this gap in care.
NUE Life Health serves individuals seeking progressive and integrated mental wellness solutions. The company's vision is to establish a new paradigm for mental health, focusing on catalyzing lasting change through innovative therapies and sustained digital support. It aims to empower users to heal and grow, ultimately fostering profound improvements in their mental health journey.
NUE Life Health has raised $26.0M across 2 funding rounds.
NUE Life Health has raised $26.0M in total across 2 funding rounds.
NUE Life Health has raised $26.0M in total across 2 funding rounds.
NUE Life Health's investors include James Joaquin, Pareto Holdings, Magic Venture Capital, Myelin VC, Palm Drive Capital, Alexandra Tynion, 20VC, Anti fund, Astir Ventures, Atomic, Banana Capital, Adeyemi Ajao.
NUE Life Health is a Miami-based telemedicine technology company that builds a digital platform for psychedelic-assisted and ketamine therapy, combining at-home medication delivery, virtual therapy and integration programs, and data-driven monitoring to treat mental health conditions such as depression, anxiety, and PTSD[1][4].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: NUE Life Health is a well‑capitalized, tech‑forward operator in the emerging psychedelic telehealth space that differentiates through an integrated at‑home ketamine care pathway, provider partnerships, and data‑driven monitoring—positioning it to play a meaningful role as psychedelic therapies move toward mainstream clinical adoption[4][2][1].
NUE Life Health has raised $26.0M across 2 funding rounds. Most recently, it raised $23.0M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $23.0M Series A | James Joaquin | Pareto Holdings, Magic Venture Capital, Myelin VC, Palm Drive Capital, Alexandra Tynion |
| Jun 1, 2021 | $3.0M Seed | 20VC, Anti fund, Astir Ventures, Atomic, Banana Capital, Adeyemi Ajao, Bessemer Venture Partners, Boost VC, Buckley Ventures, Dragonfly Capital Partners, Expon Capital, Foundation Capital, Founders Fund, Andrew Wheeler, Bernardo Hernandez, Incite Ventures, Insight Partners, Kepler Operator’s Fund, Khosla Ventures, Kleiner Perkins, Long Journey Ventures, Mayfield, Oak HC/FT, Offline Ventures, Pareto Holdings, Plug & Play Ventures, Primetime Partners, Refactor Capital, SV Angel, Nicholas Shekerdemian, Y Combinator, Charlie Songhurst, Greg Kidd, Jaan Tallinn, Josh Mohrer, Kunal Shah, Louis Beryl, Mandeep Singh, Omid Ashtari, Paul Forster, Peter Pastewka, Sam Altman, Scott Banister, Christina Getty, Jack Abraham, James Bailey, Jon Oringer, Martin Varsavsky, Shervin Pishevar |